Clairo

Technical Product Manager

United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Clinical Trials, BiotechnologyIndustries

Requirements

Candidates must possess a Bachelor's degree in business, science, technology, or medicine, with an MBA being preferred. A minimum of 3 years of product management experience, ideally within healthcare or clinical trials, is required. Strong technical acumen, full product lifecycle experience, and proven success collaborating with UX/UI teams are essential. Deep knowledge of healthcare, life sciences, or medical device domains, excellent prioritization and agile collaboration skills, and strong customer engagement and communication abilities are necessary. Experience in respiratory data capture or clinical technology solutions, managing medical devices for vital signs monitoring or diagnostics, FDA 510(k) submission experience, and knowledge of 21 CFR Part 11 compliance are required. Familiarity with CE Marking, global medical device approvals, device security, GMP, MDD, MDR, and regulatory compliance frameworks are preferred. Strong presentation skills and the ability to make resilient, proactive decisions are also sought.

Responsibilities

The Technical Product Manager will partner with Product Line Leaders and Upstream Product Managers to align roadmaps with product vision and launch timelines. They will monitor market dynamics and new technologies to inform strategy and prioritize features, developing and maintaining multi-year release roadmaps. Responsibilities include defining system architecture, user experience, and key product capabilities in collaboration with technical teams, and leading business architecture and workflows for assigned product components. The role involves acting as a subject matter expert for cross-functional initiatives, leading release readiness activities, and representing the product team in stakeholder and client-facing meetings. Providing leadership and coaching for individual contributors may also be part of the role.

Skills

Product Management
Technical Acumen
Roadmap Development
Business Architecture
Stakeholder Management
Agile Methodologies
Clinical Trials
Healthcare Technology
Data-Driven Product Development
MVP Validation
User Documentation
Release Readiness

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI